Philip Low Email

Chief Science Officer . Endocyte

West Lafayette, IN

Location

p***@purdue.edu

Primary Email

LinkedIn

Current Roles

Employees:
18
Revenue:
$1.8M
About
Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma.
Endocyte Address
Purdue Research Park
West Lafayette, IN
United States
Endocyte Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.